TickerFactsScreenerDevelopers

Aclaris Therapeutics, Inc. (ACRS) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $1.21M2018: $4.33M2019: $4.05M2020: $5.13M2021: $4.71M2022: $4.02M2023: $3.42M2024: $2.79M2025: $2.09M$2.09M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$2.09M-25.1%
2024$2.79M-18.4%
2023$3.42M-14.9%
2022$4.02M-14.6%
2021$4.71M-8.2%
2020$5.13M+26.6%
2019$4.05M-6.3%
2018$4.33M+258.7%
2017$1.21M—